987 UNICEF Kenya Mpox Plan_excl_foreword_low res

Page 1


National Mpox Risk Communication and Community Engagement Plan: Kenya

National Mpox Risk Communication and Community Engagement Plan: Kenya Ministry of Health, Republic of Kenya, Nairobi, August 2024

Abbreviations and acronyms

COVID-19 coronavirus disease 2019

IEC information, education and communication

IHR International Health Regulations (2005)

IVR interactive voice response

MoH Ministry of Health

mpox monkeypox

OPXV Orthopoxvirus

PCR polymerase chain reaction

RCCE risk communication and community engagement

UNICEF United Nations Children’s Fund

USSD Unstructured Supplementary Service Data

WHO World Health Organization

Definition of key terms

(Community) lay case

Any person with hotness of the body, no response to treatment and a rash, and history of travel to a country reporting cases of mpox

Infodemic The rapid spread of myths, misconceptions and misinformation

Mpox (monkeypox) viral zoonotic disease (a virus transmitted to humans from animals) that occurs primarily in the tropical rainforest areas of Central and West Africa, which is occasionally exported to other regions.

Probable case

Suspected case

A person meeting the case definition for a suspected case and one or more of the following:

• Has an epidemiological link (prolonged face-to-face exposure in close proximity, including health workers without appropriate personal protective equipment (gloves, gown, eye protection, and respirator); direct physical contact with skin or skin lesions, including sexual contact; or contact with contaminated materials such as clothing, bedding or utensils) to a probable or confirmed case of mpox in the 21 days before symptom onset

• Has had multiple or casual sexual partners in the 21 days before symptom onset

• Has detectable levels of anti- Orthopoxvirus (anti-OPXV) IgM antibody (during the period of 4–56 days after rash onset) or a four-fold rise in IgG antibody titre based on acute (up to days 5–7) and convalescent (day 21 onwards) samples; in the absence of recent smallpox/mpox vaccination or other known exposure to OPXV

• Has a positive test result for orthopoxviral infection (e.g., OPXV-specific polymerase chain reaction (PCR) without monkeypox-virus-specific PCR or sequencing)

person of any age presenting with an unexplained acute rash or one or more acute skin lesions; and one or more of the following signs or symptoms: headache, acute onset of fever (>38.5°C), lymphadenopathy (swollen lymph nodes), myalgia (muscle and body aches), back pain, asthenia (profound weakness; and history of travel to a country recording confirmed (monkeypox virus) mpox cases (currently, Democratic Republic of Congo, Uganda, Burundi and Rwanda) or contact with somebody who has been with a person with the above symptoms within the last three weeks and travelled to a country with confirmed cases

Introduction

Kenya recorded its first case of monkeypox virus (mpox) on 22 July 2024. At the regional level, Kenya’s neighbouring countries of the Democratic Republic of the Congo, Rwanda and Uganda have continued to report more cases, putting Kenya at an increased risk of more infections.

Since the declaration of the mpox outbreak in Kenya, a series of other regional and global events have followed, with the Africa Centres for Disease Control and Prevention declaring mpox a public health emergency of continental security on 13 August 2024. Another declaration, of mpox as a public health emergency of international concern under the International Health Regulations (2005), followed on 14 August 2024. The outbreak and the subsequent pronouncements by the World Health Organization (WHO) and Africa Centres for Disease Control and Prevention signal the need for consolidated efforts in the prevention and control of mpox as a public health emergency with calls for global solidarity in mobilizing vaccine doses.

While mpox is not new, its resurgence in non-endemic regions has raised concerns about its transmission, diagnosis and management. As the world continues to navigate the complexities of global health security, understanding and addressing the challenges posed by mpox is crucial.

With Kenya intensifying active surveillance and contact tracing, there is an urgent need to initiate risk communication and community engagement (RCCE) to prepare the public in observing mpox preventive measures, taking action in the event of a suspected case and monitoring and managing infodemics associated with mpox.

In developing the National Mpox Risk Communication and Community Engagement Plan the country is guided by the National Mpox Plan (2024), which assumes three scenarios (see Table 1, p. 7).

RCCE involves two-way communication with communities, their leaders, health personnel and response teams to improve knowledge and awareness of mpox based on community contexts. It addresses community concerns and builds and maintains trust and confidence, resulting in early/timely adoption of positive health-seeking behaviours by adherence to prescribed public health measures.

This National Mpox Risk Communication and Community Engagement Plan provides a guide for the implementation of evidence-based activities designed to increase knowledge and awareness through sharing accurate and timely information; increase utilization of prevention measures; and facilitate adoption of protective behaviours across the country and specifically within targeted and affected locations.

Table 1: Mpox case scenarios and proposed RCCE activities

Scenarios Number of cases and counties affected

Scenario 1: Best case Limited transmission with 1–99 cases and no further spread

Scenario 2: Moderate Regional spread with fewer than five counties affected (100–1,000 cases reported)

Proposed RCCE activities and their intensity

Enhance RCCE interventions, such as advocacy, with key influencers; mass media engagement, including press releases and media briefings to inform the public status of preparedness; and community engagement to rally the public to adhere to protective behaviours and address concerns and infodemics associated with mpox.

Intensify RCCE activities and disseminate key messages through mass media (radio and TV spots) and social media posts (Facebook, X, etc.). Track rumours, hold regular press releases and social mobilization activities (public address systems, stakeholder and community meetings, etc.). Provide a two-way mechanism for listening to and providing feedback to the public. The priority is to give information to the public on risk drivers of the mpox outbreak and ways to protect themselves, their households and the entire community.

Scenario 3: Worst case National spread beyond five counties, community transmission established (1,000–9,999 reported cases)

All RCCE interventions to be scaled up through the active engagement of stakeholders. Continue to provide information on key drivers of the outbreak and negative behaviours that promote transmission via human-to-human contact. Regularly monitor the outcome and impact of the key messages being given to community members.

Guided by the National Mpox Plan (2024), RCCE activities will be targeted to prioritise high-risk routes of mpox introduction into Kenya: mainly, (i) the road transport network from Uganda to Mombasa, (ii) crossborder movement along border counties, (iii) international airports and (iv) referral hospitals (see Table 2).

Route of mpox introductionHigh-risk counties, airports and health facilities

Road routes from Uganda to Mombasa

Cross-border movement along border counties

International airports

Route 1 (Busia route): Busia – Kisumu – Kericho – Nakuru – Kiambu –Nairobi –Machakos – Kajiado – Makueni – Taita Taveta – Kwale – Kilifi –Mombasa

Route 2 (Malaba route): Busia – Bungoma – Eldoret –Nakuru – Kiambu – Nairobi – Machakos – Kajiado –Makueni –Taita Taveta – Kwale – Kilifi –Mombasa

9 counties: Migori, Homa Bay, Kisumu, Siaya, Busia, Bungoma, Trans Nzoia, West Pokot, Turkana

• Jomo Kenyatta International Airport, Nairobi

• Moi International Airport, Mombasa

• ilson Airport

Table 2: High-risk routes of mpox introduction

Route of mpox introductionHigh-risk counties, airports and health facilities

Referral hospitals that receive patients from Uganda

• National referral hospitals: Kenyatta National Hospital and Moi Teaching and Referral Hospital

•Major private and mission hospitals: Nairobi Hospital, Aga Khan University Hospital (Nairobi), Mater Misericordiae Hospital, MP Shah Hospital, Gertrude Children’s Hospital, Karen Hospital, Mombasa Hospital, Aga Khan Hospital (Kisumu) and their outlet clinics

• County referral hospitals in the border counties

Justification

While mpox has been in existence since the 1970s, its emergence in non-endemic countries like Kenya poses a challenge, with the public likely to associate it with a novel infection. This calls for a robust RCCE plan to respond to the public’s low perception of risk and knowledge of mpox and its prevention and control measures, while monitoring and responding to any infodemics associated with the infection.

In spite of efforts by the Ministry of Health (MoH) and partners on supporting RCCE preparedness and response, there are existing challenges that need to be addressed urgently. These include:

• Lack of an RCCE strategic plan and guidelines in support of mpox prevention and control that are specific to high-risk counties.

• Lack of readily available funds to support and scale up the RCCE activities.

• Limited knowledge and awareness of mpox in the community, including preventative measures, leading to low perception of risk.

• The need to scale up cross-border RCCE coordination and sharing of information, as a result of crossborder movement of populations along the country’s international boundaries. Lack of experience of health-care workers having handled mpox as a routine medical condition. This may create fear, and impact health-care workers and client communication during case management.

RCCE is an essential pillar of the national mpox preparedness and response plan and crucial to the provision of accurate and credible information and advice to prevent exposure and spread.

Objective

To raise communities’ risk perception on mpox by implementing data-driven and community-led RCCE interventions to promote and increase adherence to recommended mpox prevention and control measures among community members.

Specific objectives

1. Increase community knowledge and awareness of the mpox outbreak in Kenya.

2. Increase uptake of mpox preventive measures by the public and specific high-risk communities (improved practices).

3. Monitor and respond timeously to mpox infodemics (myths, misconceptions and misinformation).

4. Improve and build confidence in the health-care worker through client communication.

Strategic approach

Elements included in the strategic approach contained in this National Mpox Risk Communication and Community Engagement Plan are:

• coordination

• advocacy

• communication

• infodemic management

• social mobilization and community engagement

• capacity-building monitoring and evaluation.

Coordination

• An mpox RCCE working group will be formed as part of the national Incident Management System. The working group will draw membership from the MoH’s Department of Health Promotion, Division of Disease Surveillance and Response Unit; United Nations agencies (WHO, United Nations Children’s Fund (UNICEF)); the United States Agency for International Development; and international nongovernmental organizations (Kenya Red Cross Society, Amref Health Africa), among others.

• The working group will be guided by terms of reference.

• The working group will meet on a regular basis to develop and review the RCCE plan and monitor the progress of implementation of RCCE activities during the response period.

• The meetings will be held either virtually or in person.

• Capacity-building and strengthening will be supported to incorporate RCCE into integrated trainings for health-care providers.

Cross-border county coordination of RCCE interventions and sharing of updates will be strengthened.

Advocacy

The primary objective of advocacy is to ensure effective buy-in of policymakers and decision makers to own and support mpox RCCE activities. It involves engaging stakeholders who have an influence over the community and includes political, social or administrative leadership. It is expected that upon engagement, the stakeholders will commit to and support advocating for mpox awareness-creation and the uptake of mpox prevention measures at national, county and subcounty levels.

Planned advocacy activities

• Hold a national advocacy meeting that will culminate in a media briefing for high-level national dissemination.

• Support county and subcounty levels to conduct advocacy meetings in affected locations. Support local advocacy meetings in any location that will report local cases.

Communication

Communication aims at ensuring that mpox messages and materials are always available through a variety of communication channels that are appropriate to different target audiences. Given that everyone is at risk of mpox, the communication strategy will target all members of the community.

The communication plan will be guided by an mpox communication matrix (see Table 2).

Item

Problem statement

Changes the programme calls for

Detail

While mpox is not a new infection, its emergence and regional spread into non-endemic countries presents as a novel infection. Novel infections are often associated with public misinformation, rumours and myths. There is limited knowledge and awareness of the disease and its modes of transmission, and prevention and control measures. With mpox occurring soon after the global coronavirus disease 2019 (COVID-19) pandemic, there are also fears and worries among the public that the measures associated with COVID-19 control will be reintroduced, i.e., quarantine, social distancing and vaccination.

• Increase knowledge and awareness of mpox and preventative measures.

• Institute systems to track, monitor and respond to infodemics associated with mpox.

• Build public community trust and confidence in the national ability to prevent and control mpox.

• trengthen health-care worker–client communication during mpox case management.

Audience segmentation

Primary audience

Everyone at risk of mpox, high-risk counties, truck drivers, commercial sex workers

Secondary audience Caregivers, frontline health-care workers, health management teams (including health promotion staff), journalists and media influencers, school-aged children, teachers and headmasters, community-level key influencers and opinion leaders, civil society organizations and groups

Tertiary audience

Policymakers; political, social and administrative leaders; partners

Table 3: Mpox communication plan

Item Detail

Primary audience

Desired changes

Key barriers

Specific communication objectives

• Increased knowledge and awareness of mpox prevention and control

• Public trust and confidence in the management of mpox so members of the public can present themselves with suspected cases

• Monitoring and response to infodemics associated with mpox

• Limited knowledge of mpox among the public

• Limited confidence in handling mpox cases among health-care workers

• Widespread infodemics on mpox on social media and in community conversation, including mistrust of government by the public

• uboptimal infodemic management and coordination in MoH

1. Increase knowledge and awareness of the mpox outbreak in Kenya

2. Increase uptake of mpox preventive measures by the public and specific high-risk communities

3. Monitor and respond timeously to mpox infodemics (myths, misconceptions and misinformation)

4. Improve and build confidence in the health-care worker through client communication

Communication channels

Communication materials

Themes of key messages

• Social and mass media

• nterpersonal communication

• Printed information, education and communication (IEC) materials

• Social media posts

• Press releases and alerts

1. Who is at risk? Everyone is at risk of mpox.

2. What is mpox and what are its signs and symptoms?

3. How is mpox transmitted?

4. How can protect myself against mpox?

5. What should do if suspect have mpox?

6. How should I take care of someone with mpox?

7. What is the treatment for mpox?

Secondary audience

Desired changes

Key barriers

Specific communication objectives

Communication channels

• Promote and spread the key messages to increase public knowledge and awareness, acting as a trusted source of information

• Timely community-based identification and reporting of suspected cases and concerns

• Though mpox has been in existence for many years (since 1970), this is the first time Kenya is reporting cases and the public perceives it as a novel infection

• Since the COVID-19 pandemic, the public has developed a mistrust in the government and the situation is worsened by the current political unrest in the country

• Increased knowledge and awareness of mpox and preventative measures

• Provide space for reaching communities with health education and promotion activities

• Community-based reporting of suspected cases and reporting to appropriate authorities

• Identification of and timely response to infodemics

• Coverage by journalists and media

Item Detail

Communication materials

Key messages

• Press briefs

• EC materials targeting school-age pupils

• nterpersonal communication materials for frontline workers, including guidelines and lay case definition

• TV and radio messages (may be used in other media, e.g., thumb drives for use in different settings)

• Social media posts

• Vehicles with public address systems mounted on them

• Barazas

1. Who is at risk? (Everyone is at risk of mpox.)

2. What is mpox and what are the signs and symptoms of mpox?

3. How is mpox transmitted?

4. What is the treatment for mpox?

5. What is the risk to self and others?

6. What are key messages on mpox I need to share?

7. Where can get more information? Who are the contacts?

8. Where and how to report suspected cases? What is the lay case identification?

9. How can prevent the spread of mpox?

Tertiary audience

Desired changes

Key barriers

Specific communication objectives

Communication channels

Communication materials

• Promoting and spreading key messages to increase public knowledge and awareness

• nderstanding their role in preparedness and response

• Coordinating with national and county authorities

• Ownership of response activities and addressing infodemics at the source

• Though mpox has been in existence for many years (since 1970), this is the first time Kenya is reporting cases, so the public perceives it as a novel infection

• Increased knowledge and awareness of mpox and preventative measures

• Provide space for reaching communities with health education and promotion activities

• Community-based reporting of suspected cases and reporting to appropriate authorities

• Identification and timely response to infodemics

• Stakeholder meetings and community dialogue sessions

• Mpox sensitization meetings with staff

• EC materials

• Advocacy briefs

• MoH specific alerts

• Line ministry communiqués

Planned communication activities

• Develop mpox RCCE messages and material, i.e.:

• print materials

• audio or radio messages (may be used in other media, e.g., thumb drives for use in different settings)

• audiovisual media

• social media.

• Print and disseminate mpox messages and materials.

• Deploy vehicles with public address systems mounted on them to conduct street-to-street key message dissemination, including at all high-traffic areas such as markets, water points and food distribution sites.

• Support RCCE activities at points of entry, promote cross-border stakeholders’ meetings and develop joint IEC materials (print and electronic media).

Support RCCE activities at school settings and through school health clubs.

Infodemic management

Though mpox has been in existence for some years, its first occurrence within Kenya is likely to be viewed as a novel event and associated with myths and misconceptions. This was evident following an MoH press release to which the public seemed to exhibit mistrust in the government. Infodemic management will be used to track and provide timely responses to community feedback in high-risk areas.

Planned activities

1. Standardize infodemic management guidelines: Finalize the development of comprehensive infodemic management guidelines for national and county levels. This activity will ensure that guidelines include clear protocols and procedures for identifying, addressing and mitigating misinformation related to mpox.

2. High-level coordination meeting: Conduct a high-level meeting involving representatives from national and county levels, key partners and stakeholders. The objective is to align and streamline infodemic management efforts and establish a cohesive system for tracking of and response to misinformation.

3. Establish real-time tracking and reporting channels: Implement real-time reporting channels such as hotlines, Unstructured Supplementary Service Data (USSD) codes, QR codes, web links and mobile platforms in counties at high risk and at border points. These channels will allow community members to directly report misinformation or any concerns related to mpox promptly and efficiently.

4. Develop debunking content timeously (in English and Swahili) to be shared through various online and offline channels.

5. Map dissemination channels, including online and offline influencer channels.

6. Offline data collection tool development for county health promotion officers and community health promoters: Develop and distribute a standardized tool that county health promotion officers and community health promoters can use to report rumours and misinformation encountered in their communities. The tool should be easy to use and integrate seamlessly into their routine activities.

7. Infodemic management training modules: Create specialized training modules for county health promotion officers and community health promoters focusing on the identification and debunking of misinformation in the community. These modules should cover techniques for effective communication and community engagement.

8. County health promotion officer and community health promoter training sessions: Conduct comprehensive training sessions for county health promotion officers and community health promoters on how to identify misinformation and communicate accurate information effectively. Ensure that these sessions include practical exercises and role-playing scenarios.

9. Public knowledge, attitude and practice assessments: Perform targeted public assessments in counties at risk and at border points to gauge community knowledge, attitudes and practices regarding mpox.

10. Engagement with influencers and leaders: Organize meetings with key social media influencers, religious leaders and community leaders to discuss public concerns about mpox. Provide them with accurate information and strategies to debunk rumours within their spheres of influence.

11. Documentation and sharing of success stories: Collect and document success stories in infodemic management interventions applied during mpox. These will be shared through newsletters, social media and community meetings to inform and inspire future efforts.

Social mobilization and community engagement

The aimis to gain and maintain the involvement of a broad range of groups and sectors in supporting mpox RCCE activities. Communities and families will be engaged through local community networks such as local leaders, faith-based organizations and women and youth groups to develop appropriate knowledge and skills that promote and enhance health and welfare and that stimulate demand for and acceptance of services. This will mainly be channelled through collaboration and partnership with local power structures and cultural networks, including faith-based organizations. These groups will include both the public and private sectors, other non-health government sectors, non-governmental organizations and the media. The aim is to engage social groups, stakeholders and community-based organizations to motivate communities to collectively participate in adherence to mpox preventative measures

Activities

• Develop a social mobilization and community engagement guide.

• Support affected counties to identify and engage community social groups, influencers and leadership, including religious and cultural leaders, to advocate and support.

• Develop a community mpox package for community health promoters.

• Support affected counties to sensitize community health promoters.

• Support community health promoters in affected counties to raise awareness on mpox and facilitate the uptake of mpox prevention and control services through interpersonal and house-to-house communication within their catchment areas.

• Support community dialogue with health service providers and community health promoters to identify issues and challenges and the means to overcome them through community-led sessions.

• Conduct awareness sessions in targeted public places in target counties and subcounties, engaging influencers to answer questions and concerns of targeted communities and disseminating IEC materials to target groups.

• Activate religious and traditional networks to increase credibility, support, reach and acceptance of protective behaviours.

• Deploy vehicles with public address systems mounted on them to conduct street-to-street key message dissemination including at all high-traffic areas such as markets, water points and food distribution sites. Support cross-border RCCE stakeholder meetings and dialogues and develop joint IEC materials, including print and electronic media.

Mpox RCCE preparedness and response scenarios

Given the evolving mpox outbreak situation in the region, scenarios for RCCE preparedness and response to the outbreak have been broadly categorized into two scenarios aimed at strengthening response and preparedness priorities:

• Low-risk scenario: One index case (recovered) and a few other cases identified in one or more counties, and treated.

Moderate or high-risk scenario: Risk of transmission and confirmation of mpox cases in 13 high-risk and several medium-risk counties.

Mpox RCCE activity plan

The activity plan (Table 4) for mpox RCCE is expanded into a schedule of activities for 2024 (Table 5) and a budget (Table 6).

Table 4: Mpox RCCE activity plan

ActivitiesSub-activities

Advocacy activities

Hold a national advocacy meeting with key stakeholders (civil society, religious groups, media houses, medical associations), among others.

Hold subcommittee meetings

Media briefing, issue press releases and advisories

Communication activities Design communication products (posters, social media toolkits)

Develop key messages

Approve key messages

Produce radio and TV spots

Air radio and TV spots

Social mobilization

Frequency Remarks

Weekly/when necessary Requires financial support

Weekly/when necessary Ongoing

Weekly/when necessary To be undertaken by Director General, Principal Secretary or Cabinet Secretary

Weekly/when needed Pending/awaiting approval of key messages)

When necessary Done

When necessary Pending approval

Develop initial spots; more when necessary Requires financial support

Monthly basis Requires financial support

Media talk shows by technical leadsWhen available List of focal persons and spokespersons

Disseminate social media messages

Disseminate messages at points of entry using bulk SMS, interactive voice response (IVR), USSD, 719, posters, electronic screens

Disseminate key messages using public address systems and megaphones, targeting 13 high-risk counties

Community engagement Sensitize community health resource persons, non-governmental organizations and community leaders (teachers, religious leaders, youth leaders, women leaders, etc.)

Daily Awaiting approval

Daily Awaiting approved messages and financial support

Requires financial support

Requires financial support

Monitoring and evaluation

Build capacity of national staff Once Requires financial support

Build capacity of county and subcounty staff

Undertake door-to-door mobilization and community dialogues

Monitor rumours and misinformation

Cascading schedule Requires financial support

Requires financial support

Requires financial support

Hold a national advocacy meeting with key stakeholders (civil society, religious groups, media houses, medical associations), among others

Brief media, issue press releases, alerts and advisories

Media talk shows by technical leads and senior leadership

Disseminate social media messages

2 wk. 3

Showcase MoH interventions, including storytelling on mpox

Disseminate messages at points of entry using bulk SMS, IVR, USSD 719, posters, electronic screens

Disseminate key messages using public address systems and megaphones

Sensitize community health resource persons, non- governmental organizations and community leaders (teachers, religious leaders, youth leaders, women leaders, etc.)

Build capacity of national staff

Social mobilization

Community engagement

Build capacity of county and subcounty staff

Undertake door-todoor mobilization and community dialogues

Monitor rumours and misinformation

Community and communication

Table 6: Budget for mpox activities

Capacity-building

Capacity-building is working with and supporting service providers, communities and institutions to build and develop skills, structure and knowledge to enable them to engage in consultation, define objectives and achieve results and ultimately achieve change that is anchored in the principles of empowerment and equality. Key community members and organizations, as well as other public and private sector partners, staff and volunteers involved in RCCE activities, will receive training and capacity-building with sessions implemented at national, county and subcounty levels in a cascading fashion, commencing with training of trainers.

Activities

• Develop mpox RCCE training materials for health-care workers and community health promoters.

• Build the capacity of health-care workers on the mpox RCCE module during integrated mpox prevention and management training.

• Train county and subcounty health promotion officers, community health promoters and social mobilizers on how to identify and where to refer potential cases who need medical attention, in a cascaded fashion. Provide supportive supervision, documentation of lessons learned and quality reporting.

Monitoring and evaluation

The goal of the monitoring and evaluation plan (see Table 6) is to ensure that the mpox RCCE planned activities are implemented and have achieved the expected results (or not).

Indicators

Number of meetings held, number of communication plans developed, number of key messages developed

Team able to work on key messages, communication plan and response plan, based on the objectives

Availability of minutes

An active RCCE technical working group formed

Virtual meeting conducted for members, activation of Incident Management System structure

Activation of RCCE working group by MoH (national and in counties) and partners

Form mpox RCCE technical working group

Number of meetings held, number of challenges listed, number of key messages produced, number of strategies developed

RCCE support, improved mpox RCCE interventions

Availability of minutes, venue name

The following were discussed: Challenges, key messages and strategic plan

Virtual and physical meetings held

Holding weekly meetings

Hold regular mpox RCCE working group meetings

Total amount of budget, number of key messages produced

Draft plan, budget, draft messages

Availability of the draft plan

Communication, advocacy, mass media, infodemic management, budget, key messages

Strategic areas identified, teams formed to support different thematic areas

Identify key strategic areas for strategic plan, form thematic area teams

Develop Mpox RCCE Plan for Kenya

Number of stakeholders reached, national advocacy stakeholder meeting held

Stakeholders identified, meeting held

Availability of minutes for the meeting, attendance list

National advocacy stakeholder meeting held

Hold meeting with various stakeholders

Stakeholder mapping, national mpox advocacy meeting planned (date and venue)

Hold a national advocacy meeting that will culminate in a media briefing for highlevel national dissemination

Number of counties and subcounties listed, number of meetings held

Counties and subcounties identified, advocacy meetings held

List of high-risk and affected counties and subcounties

Risk assessment done, affected counties listed, advocacy meetings held

Identify highrisk counties, hold virtual or physical meetings

Map high-risk counties, list counties along the transport corridor

Support county and subcounty levels to conduct advocacy meetings in affected locations

Advocacy

Local leaders participate in RCCE activities at local levels

Attendance list, meeting agenda

Number of local leaders reached

Sensitization meetings

Hold advocacy meetings with local leaders

Support local advocacy meeting in any location that will report local cases

Number of local leaders engaged Communication

Number of IEC products designed

Materials developed and produced for various audiences

Number of IEC products printed

Local purchase orders and actual IEC printed

Local purchase orders, local service orders and delivery notes

materials designed and pretested

Drafted and approved key messages

Suppliers identified for printing the IEC materials

Requisition of supply firms to undertake printing, quotations issued, etc.

Determine numbers of IEC materials to be printed and provide terms of reference

Number of channels listed, number of contact persons on list

Scripts developed and produced for various audiences

List of all channels, availability of scripts

Identify and list channels, list of contact persons

Draft scripts for audio messages

Map channels for communication (radio)

Print materials

Advocacy (cont.)

Number of channels listed, number of contact persons on list, number of scripts produced

Scripts developed and produced for various audiences

List of all channels, availability of scripts

Identify and list channels, list of contact persons

Draft scripts for audiovisual messages

Map channels for communication (audiovisual messages)

Audio messages

Audiovisual messages

Social media messages created, increased subscribers on social media platforms, monitoring of responses and feedback on platforms

Meeting minutes, content drafts, platform analytics, feedback mechanism

Areas of discussion identified, number of messages created, engagement matrices (likes, shares and comments)

Create and publish messages, increased engagement on social media platforms

Budget allocation, tool identification, partnership engagement

Identify key areas for engagement, develop content (text, videos)

Social media messages

Indicators of success

Outcome

Materials printed and distributed

Increased knowledge of mpox, adoption of preventive measures

Means of verification

Output

Print receipts, distribution receipts, verification records, feedback surveys

Materials printed and distributed

Input

Process

Source of funding, human resources, materials, technology, partnerships

Design, print and distribute mpox materials, conduct community engagement

Print and disseminate mpox messages and materials

Communication (cont.)

Deployment days, locations covered, sessions, participants, feedback responses

Increased awareness, enhanced engagement, adoption of key behaviours

Session attendance, feedback forms

Number of days of deployment, locations for deployment, number of sessions

Funding, equipment, content, partnerships, logistics

Deploy vehicle with public address system, broadcast messages, engage with community

Deploy vehicle with public address system mounted on it to conduct street-to-street key message dissemination, including at all high-traffic areas such as markets, water points and food distribution sites

Printed materials, e.g., brochures, electronic materials (videos), numbers of meetings, participant booths, travellers reached, workshop participants

Increased awareness, enhanced collaboration, improved engagement

Production receipts, meeting minutes, deployment logs, attendance records, feedback surveys

Brochures produced, videos produced, meeting booths, workshops

Funding, equipment, content, partnerships, logistics

Develop IEC materials, organize crossborder meetings, deploy at points of entry, conduct community engagement

Support RCCE activities at points of entry and promote crossborder stakeholder meetings, including developing joint IEC materials (print and electronic)

Information verified, infographics, dissemination activities, monitoring reports with analytics

Reduced misinformation, increased public awareness, enhanced trust, improved engagement

Verification reports, production records, dissemination logs, monitoring reports, feedback surveys

Information verified, infographics, dissemination activities, monitoring reports with analytics

Funding, human resources, materials, partnerships, technology

Verify information, create and disseminate content, monitor and engage

Information verification

Infodemic management

Indicators

Number of materials produced, events organized, campaigns launched, sessions held, participants reached, reports

Increased awareness, enhanced engagement, improved communication, strengthened support

Event records, campaign reports, attendance records, monitoring reports

Brochures printed, events held (including launch), campaigns, sessions, monitoring reports

Funding, resources, materials, partnerships

Develop materials, organize events, launch campaigns, conduct sessions, monitor and evaluate

Develop a social mobilization and community engagement guide

Social mobilization

Groups and leaders identified, meetings held, leaders trained, events organized, advocacy activities done, feedback collected

Enhanced engagement, improved communication, strengthened support, increased advocacy impact

Identification reports, meeting minutes, training records, event records, monitoring reports

Groups and leaders identified, planning meetings, training sessions, collaborative events, monitoring reports

Funding, resources, materials, partnerships

Identify groups and leaders, conduct outreach, train leaders, foster collaboration, monitor and evaluate

Support affected counties to identify and engage community social groups, influencers and leadership, including religious and cultural leaders, to advocate and support

Needs assessment report, materials developed (fact sheets, posters), packages distributed, training sessions held, feedback collected

Improved knowledge, effective communication, increased engagement, enhanced capacity

Needs assessment report, production logs, distribution records, training records, feedback forms

Needs assessment report, educational materials (fact sheets, posters), training sessions, feedback reports

Funding, resources, materials, partnerships

Conduct needs assessment, develop content, design package, train promoters, distribute package, monitor and evaluate

Develop community mpox package for community health promoters

Needs assessment report, materials developed (fact sheets, posters), packages distributed, training sessions held, feedback collected

Improved knowledge, effective communication, increased engagement, enhanced capacity

Needs assessment report, production logs, distribution records, training records, feedback forms

Needs assessment report, educational materials (fact sheets, posters), training sessions, feedback reports

Funding, resources, materials, partnerships

Conduct needs assessment, develop content, design package, train promoters, distribute package, monitor and evaluate

Support affected counties to sensitize community health promoters

Outcome

Needs assessment report, materials developed (fact sheets, posters), packages distributed, training sessions held, feedback collected

Improved knowledge, effective communication, increased engagement, enhanced capacity

Needs assessment report, production logs, distribution records, training records, feedback forms

Needs assessment report, educational materials (fact sheets, posters), training sessions, feedback reports

Process Input

Funding, resources, materials, partnerships

Conduct needs assessment, develop content, design package, train promoters, distribute package, monitor and evaluate

Support community health promoters in affected counties to raise awareness on mpox and facilitate the uptake of mpox prevention and control services through house-to-house interpersonal communication within their catchment areas

Social mobilization (cont.)

Plans developed, materials prepared, sessions held, issues identified, solutions proposed

Enhanced communication, addressed issues, increased engagement, improved service delivery

Planning documents, material inventory, session records, issue logs, action plans, monitoring reports

Dialogue session plans, facilitation materials, sessions conducted, issues identified, solutions proposed, action plans

Funding, resources, materials, partnerships

Plan and prepare, engage community, facilitate sessions, identify solutions, implement and follow up, monitor and evaluate

Support community dialogue with health service providers and community health promoters to identify issues and challenges and the means to overcome them through community-led sessions

Needs report completed, materials developed, materials reviewed, training sessions held, participants trained

Effective implementation, informed practices

Developed training materials, successful training, number trained

Needs assessment report, training materials (manuals, training guide and presentations), materials reviewed, training sessions, evaluation reports

Funding, resources, materials, partnerships

Assess needs, plan for training sessions, develop content design and produce, review and validate, deliver training, monitor and evaluate

Develop mpox RCCE training materials for health-care workers and community health promoters

Capacity- building

Outcome

Needs report completed, materials developed, materials reviewed, training sessions held, participants trained

Effective implementation, informed practices

Training materials developed, successful training, number trained

Output

Input

Needs assessment report, training materials (manuals, training guide and presentations), materials reviewed, training sessions, evaluation reports

Funding, human resources, materials, partnerships

Assess needs, plan for training sessions, develop content design and produce, review and validate, deliver training, monitor and evaluate

Build capacity of health-care workers on the mpox RCCE module during integrated mpox prevention and management training

Capacity- building (cont.)

Needs report completed, materials developed, materials reviewed, training sessions held, participants trained

Effective implementation, informed practices

Developed training materials, successful training, number trained

Needs assessment report, training materials (manuals, training guide and presentations), materials reviewed, training sessions, evaluation reports

Funding, human resources, materials, partnerships

Assess needs, plan for training sessions, develop content, design and produce, review and validate, deliver training, monitor and evaluate

In a cascaded fashion, train county and subcounty health promotion officers, community health promoters and social mobilizers, including on how to identify and where to refer potential cases who need medical attention

Plan completed, tools designed, data collected, report completed, strategies developed, reports produced

Gaps identified, high-risk areas prioritized, informed strategies, improved response

Plan documents, tool records, data collection logs, analysis report, strategic plan, monitoring reports

Assessment plan and tools designed, data collected (responses), analysis report, strategic plan, monitoring reports

Identify funding, tools and scope, resources, materials, partnerships, technology

Plan and prepare, collect data, analyse data, report findings, develop strategies, monitor and evaluate

Conduct socio- behavioural assessments, prioritizing highrisk areas, to identify gaps in mpox knowledge, attitudes and practices to inform response interventions and strategies

Monitoring and evaluation

Indicators of success

Outcome

Means of verification

Plan completed, tools developed, visits conducted, sessions, reports produced, followup actions

Enhanced implementation, increased capacity, effective interventions, strengthened coordination

Plan documents, tool records, visit logs, session records, reports, follow-up records

Output

Input

Supervision and plan tools developed, visits conducted, sessions, reports, follow-up actions

Funding, resources, materials, partnerships, technology

Process

Plan and prepare, conduct visits, provide technical assistance, report findings, follow-up

Support MoH to conduct supervision and offer technical assistance to counties

Monitoring and evaluation (cont.)

Plan completed, stories identified, data collected, stories documented, materials disseminated

Increased awareness, knowledge sharing, enhanced visibility, informed practices

Plan documents, story records, data collection logs, documented stories, review reports, dissemination records

Documentation plan, success stories identified, data collected, interviews, documented stories, review reports, disseminate materials

Funding, tools, resources, materials, partnerships, technology

Plan, identify stories, collect data, document stories, review and approve, disseminate, monitor and evaluate

Document success stories

Tools developed, data collected, complete report, recommendations materials produced

Key lessons learned, enhanced practices, informed stakeholders

Tool records, data collection logs, analysis report, final report, dissemination records

Documentation plan, data collection tools, interviews done, focus group sessions conducted, analysis report, final report, dissemination materials

Funding, tools, resources, materials, partnerships, technology

Plan and prepare, collect data, analyse data, write report, review and validate

Documentation of post-mpox RCCE activities report and lessons learned

Monitoring

The MoH and partners will provide supervision and offer technical assistance to high- and moderate-risk counties based on national and subnational supervision plans and tools developed for the implemented RCCE interventions.

Evaluation

The purpose of the evaluation of the national mpox RCCE plan is to analyse and assess the overall strategy, focused on reducing the spread of the mpox virus. Using the five main criteria of relevance, effectiveness, efficiency, impact and sustainability, the evaluation will gather and analyse information from different sources to enable the effectiveness of the overall RCCE response in influencing key behaviours and practices to be assessed. Using a mixture of methodologies, such as desk reviews, RCCE data review and analysis, focus group discussions and key informant interviews, the evaluation will aim to answer the following questions:

1. What were the main drivers and enablers of change in attitude and behaviour at the community level?

2. What were the implemented RCCE activities and strategies, and were they successful in reaching target audiences?

3. Did RCCE interventions lead to an increase in knowledge and protective practices?

4. What were the main lessons learned and recommendations to strengthen future RCCE interventions?

Planned activities

• Conduct socio-behavioural assessments, prioritizing high-risk areas, to identify gaps in mpox knowledge, attitudes and practices to inform the response interventions and strategies.

• Support the MoH to conduct supervision and offer technical assistance to counties.

• Conduct a desk review of existing documents and secondary data, reports and reviews.

• Conduct interviews and focus group discussions with key stakeholders, MoH staff and implementing partners.

• Conduct interviews with frontline workers, people from selected communities, and media and communication personnel. ocument success stories.

Annexes

Annex 1: Contributor list

Name Organization

Gladys Mugambi

Wycliffe Matini

Collins Chimuti

Francis M. Mutia

Gideon Kigen

Esther Bundi

Judy Sheri

Caleb Chemirmir

Joseph Othieno

Head, Department of Health Promotion, MoH

RCCE Focal Point, Division of Disease Surveillance and Response, MoH

Department of Health Promotion, MoH

Department of Health Promotion, MoH

Department of Health Promotion, MoH

Division of Disease Surveillance and Response, MoH

Public Communications, MoH

Kenya Red Cross Society

Food and Agriculture Organization of the United Nations

Leila Abrar UNICEF

Ayub Duale UNICEF

Ben Adika WHO

Gerry Geoffrey Mtike

International Organization for Migration

Annex 2: Standing recommendations for mpox

Extension of the Standing Recommendations for Mpox Issued by the Director-General of the World Health Organization (WHO) in Accordance with the International Health Regulations (2005)

These standing recommendations are issued by the Director-General of the World Health Organization (WHO) in accordance with provisions of Articles 16 to 18, and 50 to 53 of the International Health Regulations (2005) (IHR or Regulations).

These standing recommendations, based on scientific principles and evidence, represent an extension of the standing recommendations for mpox issued on 21 August 2023, taking into consideration the advice of the IHR Review Committee regarding standing recommendations for mpox.

The extension of these standing recommendations is necessary to support States Parties in addressing the risk posed by mpox and to prevent or reduce the international spread of disease.

These standing recommendations are in effect for all States Parties until 20 August 2025.

These standing recommendations may be modified or terminated prior to that time, in accordance with Article 53 of the Regulations. Furthermore, they will be submitted to the Seventy-eighth World Health Assembly for its consideration, pursuant to Article 53 (g) of the IHR.

A. States Parties are recommended to develop and implement national mpox plans that build on WHO strategic and technical guidance, outlining critical actions to sustain control of mpox and achieve elimination of human-to-human transmission in all contexts through coordinated and integrated policies, programmes and services. Actions are recommended to:

1. ncorporate lessons learned from evaluation of the response (such as through intra- or afteraction reviews) into related plans and policies in order to sustain, adapt, and promote key elements of the response and inform public health policies and programmes.

2. im to eliminate human-to-human transmission of mpox by anticipating, detecting, preparing for and responding to mpox outbreaks and taking action to reduce zoonotic transmission, as appropriate.

3. Build and retain capacity in resource-limited settings, and among marginalized groups, where mpox transmission continues to occur, to improve understanding of modes of transmission, quantify resource needs, and detect and respond to outbreaks and community transmission.

https://www.who.int/publications/m/item/standing-recommendations-for-mpox-issued-by-the-director-general-of-theworld-health-organization-(who)-in-accordance-with-the-international-health-regulations-(2005)-(ihr) (accessed on 6August 2024)

https://www.who.int/teams/ihr/ihr-review-committees/review-committee-regarding-standing-recommendations-formpox (accessed on 15 August 2023).

B.States Parties are recommended to, as a critical basis for actions outlined in A in support of the elimination goal, establish and sustain laboratory-based surveillance and diagnostic capacities to enhance outbreak detection and risk assessment. Actions are recommended to:

4. Include mpox as a notifiable disease in the national epidemiological surveillance system.

5. trengthen diagnostic capacity at all levels of the health-care system for laboratory and pointof-care diagnostic confir mation of cases.

6. Ensure timely reporting of cases to WHO, as per WHO guidance and Case Reporting Form, in particular reporting of confir med cases with a relevant recent history of international travel.

7. C ollaborate with other countries so that genomic sequencing is available in, or accessible to, all countries. Share genetic sequence data and metadata through public databases.

8. N otify WHO about signific ant mpox-related events through IHR channels.

C. States Parties are recommended to enhance community protection through building capacity for risk communication and community engagement, adapting public health and social measures to local contexts and continuing to strive for equity and build trust with communities through the following actions, particularly for those most at risk. Actions are recommended to:

9. C ommunicate risk, build awareness, engage with affected communities and at-risk groups through health authorities and civil society.

10. mplement interventions to prevent stigma and discrimination against any individuals or groups that may be affected by mpox.

D. States Parties are recommended to initiate, continue, support, and collaborate on research to generate evidence for mpox prevention and control, with a view to support elimination of human-to-human transmission of mpox. Actions are recommended to:

11. C ontribute to addressing the global research agenda to generate and promptly disseminate evidence for key scienti fic, social, clinical and public health aspects of mpox transmission, prevention and control.

12. C onduct clinical trials of medical countermeasures, including diagnostics, vaccines and therapeutics, in different populations, in addition to monitoring of their safety, effectiveness and duration of protection.

13. tates Parties in West, Central and East Africa should make additional efforts to elucidate mpox-related risk, vulnerability and impact, including consideration of zoonotic, sexual and other modes of transmission in different demographic groups.

E. States Parties are recommended to apply the following measures related to international travel. Actions are recommended to:

14. Encourage authorities, health-care providers and community groups to provide travellers with relevant information to protect themselves and others before, during and after travel to events or gatherings where mpox may present a risk.

15. dvise individuals suspected or known to have mpox, or who may be a contact of a case, to adhere to measures to avoid exposing others, including in relation to international travel.

16. Refrain from implementing travel-related health measures specific for mpox, such as entry or exit screening, or requirements for testing or vaccination.

F. States Parties are encouraged to continue providing guidance and coordinating resources for delivery of optimally integrated clinical care for mpox, including access to specific treatment and supportive measures to protect health workers and caregivers as appropriate. States Parties are encouraged to take actions to:

17. Ensure provision of optimal clinical care with infection prevention and control measures in place for suspected and confir med mpox in all clinical settings. Ensure training of health-care providers accordingly and provide personal protective equipment.

18. ntegrate mpox detection, prevention, care and research within HIV and sexually transmitted disease prevention and control programmes and other health services as appropriate.

G. States Parties are encouraged to work towards ensuring equitable access to safe, effective and qualityassured countermeasures for mpox, including through resource mobilization mechanisms. States Parties are encouraged to take action to:

19. trengthen provision of and access to diagnostics, genomic sequencing, vaccines and therapeutics for the most affected communities, including in resource-constrained settings where mpox occurs regularly, and including for men who have sex with men and groups at risk of heterosexual transmission, with special attention to those most marginalized within those groups.

20. Make mpox vaccines available for primary prevention (pre-exposure) and post-exposure vaccination for persons and communities at risk of mpox, taking into account recommendations of the WHO Strategic Advisory Group of Experts on Immunization (SAGE).

Geneva, 21 August 2024

Annex 3: Key mpox messages

Mpox frequently asked questions

1. What is mpox?

Mpox (monkeypox) is a disease caused by viruses that can affect both humans and animals (a viral zoonotic disease) primarily occurring in the tropical rainforest areas of Central and West Africa, which is occasionally transmitted to other regions.

2. What are the signs and symptoms of mpox?

The signs and symptoms include skin rash, fever, sore throat, headache, body aches, back pain, low energy (fatigue) and swollen lymph nodes.

3. How is mpox transmitted?

Mpox is transmitted through close person-to-person contact, for example:

face-to-face (talking or breathing)

skin-to-skin (touching or vaginal/anal)

mouth-to-mouth (kissing)

mouth-to-skin (oral sex or kissing the skin)

espiratory droplets or short-range aerosol transmission from prolonged close contact contact with contaminated materials, including bedding, towels and clothes sexual intercourse.

4. Who is at higher risk of contracting mpox?

Anyone can get mpox. However, those at higher risk of contracting the viral disease include healthcare workers, staff working at screening posts at points of entry, travellers, people nursing an infected person(s), people handling wild animals, children, pregnant women, immunocompromised individuals, people with multiple sexual partners and men who have sex with men.

5. Can mpox be transmitted through contaminated objects?

YES, mpox can be transmitted through direct contact with infected lesions or sores, or through contact with materials used by an infected person (utensils, clothing and bedding, among others), scabs or body fluids, as well as through respiratory droplets during prolonged face-to-face interaction.

6. How can mpox transmission be prevented?

To prevent mpox transmission: avoid close contact with individuals who are infected avoid touching their personal belongings limit your number of sexual partners refrain from contact with wild animals or consuming bushmeat.

7. Do we have an mpox vaccine?

Yes, there is a mpox vaccination.

8. What should I do if I suspect I have mpox?

If you suspect you have mpox, it is crucial to seek immediate medical attention or contact your local authority, including community health promoters. Avoid contact with others to prevent further transmission.

9. What is the risk of mpox during pregnancy?

Pregnant individuals should exercise caution regarding mpox exposure. Contracting the virus during pregnancy poses risks to both the foetus and newborn, including the potential for pregnancy loss, stillbirth and complications for the mother. Close contact with individuals infected with mpox should be avoided.

10. Is mpox infection severe?

While most mpox infections resolve without severe complications, some individuals may experience severe illness. Factors such as immune status can influence the severity of infection. Pregnant women, children and those with underlying health conditions are at a higher risk of severe disease.

For further information, contact the Ministry of Health Hotline at 719 or 0729471414 or 0732353535.

Health-care worker fact sheet

Overview

Mpox (monkeypox) is a viral illness caused by the monkeypox virus, a species of the genus Orthopoxvirus Two different types exist: clade and clade II.

Mpox is commonly reported in certain countries in Central and West Africa BUT in recent times it has spread to areas and countries where it was not common, like East Africa, including Kenya.

Suspected case definition

A person of any age presenting with an unexplained acute rash or one or more acute skin lesions AND

One or more of the following signs or symptoms:

Headache, acute onset of fever (>38.5°C), lymphadenopathy (swollen lymph nodes), myalgia (muscle and body aches), back pain and/or asthenia (profound weakness) AND

History of travel to a country recording confirmed mpox cases or contact with somebody who has been with a person with the above symptoms within the last three weeks or contact with somebody who has been in contact with a person with the above symptoms within the last three weeks.

Probable case definition

A person meeting the definition for a suspected case AND

One or more of the following:

Has an epidemiological link of prolonged exposure in close proximity, including health workers without appropriate personal protective equipment (gloves, gown, eye protection and respirator); direct physical contact with skin or skin lesions, including sexual contact; or contact with contaminated materials such as clothing, bedding or utensils) to a probable or confirmed case of mpox in the 21 days before symptom onset

Has had high-risk sexual exposure in the last 21 days

Has detectable levels of anti- Orthopoxvirus (anti-OPXV) IgM antibody b (during a period of 4–56 days after rash onset); or a four-fold rise in IgG antibody titre based on acute (up to days 5–7) and convalescent (day 21 onwards) samples; in the absence of a recent smallpox/mpox vaccination or other known exposure to OPXV

Has a positive test result for orthopoxviral infection (e.g., OPXV-specific polymerase chain reaction (PCR) without mpox-virus-specific PCR or sequencing) AND

History of travel to a country recording confirmed mpox cases or contact with somebody who has been with a person with the above symptoms within the last three weeks

Community lay case definition

Any person with hotness of the body, no response to treatment and a rash, and who has travelled from a country reporting mpox cases.

Common symptoms of mpox are:

• skin rash or mucosal lesions, which can last 2–4 weeks

• ever

• headache

• muscle aches

• back pain

• atigue swollen lymph nodes.

Mpox can be transmitted from:

• persons, through touch, kissing or sex

• animals, when hunting, skinning or cooking them

• materials, such as contaminated sheets, clothes or needles pregnant persons, who may pass the virus on to their unborn baby.

Mpox laboratory confirmation and diagnosis

Detection of viral DNA by PCR is the preferred laboratory test for mpox. The best diagnostic specimens are collected directly from the rash – skin, fluid or crusts – collected by vigorous swabbing. In the absence of skin lesions, testing can be done on oropharyngeal, anal or rectal swabs. Testing blood is not recommended. Antibody detection methods may not be useful as they do not distinguish between the different virus species in the Orthopoxvirus genus.

Mpox treatment and management

• Currently there is no treatment approved specifically for mpox virus. However, supportive care isprovided.

Antiviral medication (tecovirimat) is only used with severe symptoms, after clinician evaluation.

NOTE:

• Most people with mpox will recover within 2–4 weeks. People who have mpox should be cared for away from other people to avoid spreading the infection.

Mpox prevention

Mpox infection can be prevented by avoiding close contact with infected individuals, touching personal items of infected people, multiple sexual partners, contact with wild animals and eating their products (such as the meat of squirrels, rats, mice and monkeys).

Who is at risk of acquiring mpox?

Anyone can get mpox. Those at higher risk include health-care workers, staff working at points of entry, travellers, a person nursing an infected person, people handling wild animals, children, pregnant women, immunocompromised individuals, people with multiple sexual partners and men who have sex with men.

Self-care and prevention

Things to do to help the symptoms and prevent infecting others: Do

• stay home and in your own room if possible

• wash hands often with soap and water or hand sanitizer, especially before or after touching sores

• wear a mask and cover lesions when around other people until your rash heals

• keep skin dry and uncovered (unless in a room with someone else)

• avoid touching items in shared spaces and disinfect shared spaces frequently

• use saltwater rinses for sores in the mouth

• take sitz baths or warm baths with baking soda or Epsom salts for body sores take over-the-counter medications for pain like paracetamol (acetaminophen) or ibuprofen.

Don’t

• pop blisters or scratch sores, which can slow healing, spread the rash to other parts of the body and cause sores to become infected shave areas with sores until the scabs have healed and you have new skin underneath (this can spread the rash to other parts of the body).

Mpox SMSes

1. Mpox alert: Look out for symptoms like skin rash, fever, headache and body aches. Seek urgent medical care if you experience these or call 719 or 0729471414 or 0732353535 for assistance.

2. Prevent mpox: Avoid close contact with infected people. Wash hands often. Don’t share personal items. Wear protection if caring for patients. Call 719 or 0729471414 or 0732353535 for assistance.

3. Travelling? Check health advisories for your destination. Avoid areas with mpox outbreaks. Stay informed about local updates. Call 719 or 0729471414 or 0732353535 for assistance.

4. Mpox case confirmed in Taita Taveta. Stay vigilant, follow guidelines. Seek medical help if symptoms appear. Early detection is key. Call 719 or 0729471414 or 0732353535 for assistance.

5. If exposed to mpox: Monitor health for 21 days. Watch for rash, fever and body aches. Avoid close contact with others. Seek medical help if symptomatic or call 719 or 0729471414 or 0732353535 forassistance.

6. At-risk groups for mpox: Health-care workers, close contacts of patients and those with multiple sexual partners. Stay informed. Call 719 or 0729471414 or 0732353535 for more info.

7. Mpox can be severe for pregnant women, children and immunocompromised individuals. Seek immediate care if symptoms appear. Call 719 or 0729471414 or 0732353535 for more info.

8. Mpox symptoms last 24 weeks. If infected, isolate immediately and contact health-care providers. Call 719 or 0729471414 or 0732353535 for assistance.

9. Anyone can get mpox. Let’s stop its spread together. Share accurate info and support those affected. Your actions matter! Call 719 or 0729471414 or 0732353535 for more info.

10. Mpox spreads through close contact, not just sexually. Always practise good hygiene and avoid sharing personal items. Call 719 or 0729471414 or 0732353535 for more info.

TV/radio spot on mpox (30 seconds)

Announcer: message from the Ministry of Health concerning mpox (previously monkeypox) Mpox has been detected in Kenya. Be alert for symptoms like skin rash, fever and body aches. Prevent spread by avoiding close contact with infected people and practising good hygiene.

If you have symptoms, seek medical care immediately. For information, call 719 or 0729471414 or 0732353535

Stay informed, stay safe Kenya!

Radio play on mpox

Ambient sound of busy border crossing

Border officer: Next, please! Welcome to Kenya. May see your travel documents?

Traveller: Here you go, officer.

Border officer: Thank you. Before I process your entry, I need to ask you a few health-related questions. Are you aware of the recent mpox outbreak?

Traveller: Mpox? I’ve heard something about it, but I’m not sure of the details.

Border officer: No problem, I’ll explain. Dr. Muli from our health desk will assist us. Doctor?

Dr. Muli: Hello there. Mpox is a viral infection that’s been detected in several countries, including ours. We’re taking precautions at all entry points.

Traveller: see. What should know about it?

Dr. Muli: The main symptoms are skin rash, fever and body aches. Have you experienced any of these recently?

Traveller: No, haven’t.

Dr. Muli: Good. If you do develop these symptoms within the next 21 days, please seek medical attention immediately and inform them of your recent travel.

Traveller: Understood. How can protect myself?

Dr. Muli: Avoid close contact with anyone showing symptoms, practise good hygiene by washing your hands frequently and don’t share personal items like towels or clothing.

Border officer: We’re also providing this information leaflet. You can call 719 or 0729471414 or 0732353535 if you have any concerns or visit the Ministry of Health website for more information.

Traveller: Thank you both. I’ll be sure to stay vigilant.

Dr. Muli: That’s great. Remember, early detection is key. Enjoy your stay in Kenya and stay safe!

Border officer: Your entry has been processed. Welcome to Kenya!

Ambient sound fades

IVR messages (719)

Welcome to the Ministry of Health helpline. Your health safety is our priority.

Did you know you can get health messages on disease prevention and referral of health emergencies at your nearest health-care facilities?

To continue in English, press 1; to continue in Swahili, press

Theme Key messages Channels

What is mpox?

What are the signs and symptoms of mpox?

How is mpox spread?

Mpox (monkeypox) is a viral zoonotic disease (disease that can affect both humans and animals) primarily occurring in the tropical rainforest areas of Central and West Africa, which is occasionally transmitted to other regions.

Symptoms include skin rash, fever, sore throat, headache, body aches, back pain, low energy (fatigue) and swollen lymph nodes.

Mpox is transmitted through close person-to-person contact, such as:

• face-to-face (talking or breathing)

• skin-to-skin (touching or vaginal or anal contact)

• mouth-to-mouth (kissing)

• mouth-to-skin (oral sex or kissing the skin)

• espiratory droplets or short-range aerosol transmission from prolonged close contact

• contact with contaminated materials

• sexual intercourse.

Who is at higher risk of contracting mpox?

Can mpox be transmitted through contaminated objects?

How can mpox transmission be prevented?

What should I do if I suspect I have mpox?

Anyone can get mpox. Those at higher risk include health-care workers, staff working at points of entry, travellers, a person nursing an infected person, people handling wild animals, children, pregnant women, immunocompromised individuals, people with multiple sexual partners and men who have sex with men.

Yes, mpox can spread through contaminated materials such as bedding, clothing, eating utensils and sex toys.

Mpox infection can be prevented by avoiding close contact with infected individuals, touching personal items of infected people, multiple sexual partners, contact with wild animals and eating their products (such as meat of squirrels, rats, mice and monkeys).

If you suspect you have mpox, seek urgent medical attention at the nearest health-care facility or contact health-care authorities (or a community health promoter) immediately and avoid close contact with others.

Social media (Facebook, X, Instagram, TikTok, Threads), posters

Social media (Facebook, X, Instagram), videos on signs and symptoms

Social media (Facebook, X, Instagram, TikTok, Threads), videos on how mpox is spread

Social media (Facebook, X, Instagram, TikTok, Threads), videos (Who is at risk?)

Social media (Facebook, X, Instagram, TikTok, Threads)

Social media (Facebook, X, Instagram, TikTok, Threads), videos on transmission

Social media (Facebook, X, Instagram, TikTok)

Theme Key messages

What is the risk of mpox during pregnancy?

Is mpox infection severe?

Contracting mpox during pregnancy can be dangerous for the foetus or newborn infant and can lead to loss of the pregnancy, stillbirth or complications for the mother. If you are pregnant, avoid close contact with anyone who has mpox.

Most people recover fully, but some get very sick. Mpox severity depends on individual immunity, but some special groups, when infected, may have severe disease. These groups include pregnant women, children, and the immunosuppressed with underlying/chronic conditions.

Mpox dos and don’ts Do

• stay home and in your own room if possible

• wash hands often with soap and water or hand sanitizer, especially before or after touching sores

• ear a mask and cover lesions when around other people until your rash heals

• keep skin dry and uncovered (unless in a room with someone else)

• avoid touching items in shared spaces and disinfect shared spaces frequently

• use saltwater rinses for sores in the mouth

• take sitz baths or warm baths with baking soda or Epsom salts for body sores

• take over-the-counter medications for pain like paracetamol (acetaminophen) or ibuprofen.

Don’t

• pop blisters or scratch sores, which can slow healing, spread the rash to other parts of the body and cause sores to become infected; or

• shave areas with sores until the scabs have healed and you have new skin underneath (this can spread the rash to other parts of the body).

Channels

Social media (Facebook, X, Instagram, TikTok)

Social media (Facebook, X, Instagram, TikTok)

Social media (Facebook, X, Instagram, TikTok), videos on dos and don’ts

Mpox social media toolkit

We are leading a comprehensive national response to Mpox, ensuring interagency collaboration, adequate funding, and implementing policies that protect all citizens while combating stigma. Our commitment is to safeguard public health and maintain Kenya’s resilience against emerging threats.

Dr. Deborah Mlongo Barasa Cabinet Secretary for Health

We are mobilizing resources to fortify our Mpox preparedness and response capabilities. Our focus is on expanding testing facilities, intensifying public awareness campaigns, and coordinating with county health systems to ensure a uni e e ecti e ppro c to protect all Kenyans.

We are enhancing our healthcare system’s capacity to diagnose, treat, and manage Mpox cases efficiently. By equipping our medical facilities, training healthcare workers, and streamlining patient care protocols, we ensure that every Kenyan has access to timely and effective Mpox treatment. Our commitment is to excellence in medical services, even as we face emerging health challenges.

Mary Muthoni,
Harry Kimtai, CBS Principal Secretary, State Department for Medical Services
Mpox Updates

Our strategy against Mpox combines rigorous surveillance, rapid response, and evidence-based interventions. We are strengthening healthcare capacity, enhancing laboratory diagnostics, and prioritizing community engagement to effectively manage and contain this public health challenge.

Mpox Symptoms can appear 2-21 days after infection

If you experience any of these symptoms, seek

Dr. Patrick Amoth, EBS Director General for

Date Caption Poster

#MpoxAwareness

Stop Mpox Spread

Always Practice Safe Health Habits.

#MpoxAwareness

Mpox can be severe

Pregnant women, children, elderly, and persons with chronic medical conditions

Seek medical care if symptoms appear.

#MpoxAwareness

Pregnant women with Mpox can infect the unborn child

Seek medical care immediately.

Healthcare workers, people in close contact with confirmed cases, and those with multiple sexual partners have a higher chance of getting infected #MpoxAwareness

Date Caption Poster

#MpoxAwareness

#MpoxAwareness

If you’ve been in close contact with someone who has Mpox, monitor your health closely for 21 days after the last date of contact

Seek

attention if symptoms appear.

#MpoxAwareness

Date Caption Poster

#MpoxAwareness

Teach your children Good Hygiene

Teach

#MpoxAwareness

Recovery from Mpox usually takes 2-4 weeks

During this time, it’s crucial to isolate to prevent spreading the virus to others.

#MpoxAwareness

With

Early Detection Saves Life

Date Caption Poster

Annex 4: Offline data collection tool for rumours and misinformation

Introduction

This data collection tool is designed for county health promotion officers, subcounty health promotion officers, community health strategists/assistants and community health promoters. It aims to gather critical insights into public perceptions, concerns and rumours related to mpox (excluding vaccinations) in various community settings. By identifying and understanding these concerns, the tool enables targeted users to respond effectively to misinformation, tailor public health strategies and ensure accurate information dissemination, ultimately enhancing disease prevention and control efforts.

Section 1: General information

1.1. Date of data collection:

.2. ocation (select one or more):

Marketplace

Public transport

Church

ealth facility

Meeting

Chama

ther

Section 2: Awareness and sources of information

2.1. Are people in this setting aware of the risks of vaccine-derived mpox?

Yes No

If yes, what are the most common sources of information?

ealth facility

Radio

TV

ocial media

Word of mouth

Religious leaders

ther

Section 3: Concerns about mpox

3.1. What are the most common concerns about mpox in this setting? (Select all that apply.)

ear of the disease spreading

Fear of the disease causing death

Misunderstanding of how the disease is transmitted

Belief that it is a severe or untreatable disease

Belief that mpox is not a threat

Lack of trust in information from health authorities

Misinformation or rumours (specify) ther

.2. What are the most common concerns about a potential mpox vaccine in this setting? (Select all that apply.)

Fear of side effects

Belief that the vaccine is not effective

Religious or cultural objections

Lack of trust in health authorities

Misinformation or rumours (specify) ther

.3. How widespread are these concerns? ery common omewhat common

Rare

Not observed

Section 4: Identification and impact of rumours

4.1. Have you heard any specific rumours related to mpox in this setting? Yes No

.2. If yes, what is the most common rumour? (Specify.)

.3. How are these rumours affecting public perception and actions in the community?

Significant increase in fear or misunderstanding

Some impact on community behaviour

No noticeable impact

Not sure

Section 5: Reporting and actions taken

5.1. How have you responded to these concerns or rumours identified in this setting? (Select all that apply.)

Provided accurate information and education

Engaged with community or religious leaders

Referred community members to health facilities

Reported concerns to local health authorities ther

.2. What additional support do you need to better address these issues?

Training on communication strategies

More educational materials

Support from local health authorities ther

Report summary

Key findings:

Concerns and rumours most prevalent in the following locations: Most affected issue:

Recommendations for government action:

REPUBLIC OF KENYA

Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.